Imad Brema

556 total citations
20 papers, 314 citations indexed

About

Imad Brema is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Genetics. According to data from OpenAlex, Imad Brema has authored 20 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Epidemiology and 5 papers in Genetics. Recurrent topics in Imad Brema's work include Diabetes and associated disorders (4 papers), Pituitary Gland Disorders and Treatments (4 papers) and Diabetes Treatment and Management (4 papers). Imad Brema is often cited by papers focused on Diabetes and associated disorders (4 papers), Pituitary Gland Disorders and Treatments (4 papers) and Diabetes Treatment and Management (4 papers). Imad Brema collaborates with scholars based in Saudi Arabia, Ireland and Canada. Imad Brema's co-authors include John J. Nolan, Hood Thabit, Nicole Burns, Syed Muhammad Ismail Shah, Mensud Hatunic, Marc Liesa, Déborah Naón, María Isabel Hernández‐Álvarez, Chiara Chiellini and António Zorzano and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Diabetes.

In The Last Decade

Imad Brema

18 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Imad Brema Saudi Arabia 8 118 105 103 63 36 20 314
Rosa Galván Mexico 11 89 0.8× 55 0.5× 71 0.7× 98 1.6× 31 0.9× 17 350
Medini Reddy-Luthmoodoo Australia 7 87 0.7× 152 1.4× 81 0.8× 64 1.0× 64 1.8× 8 327
Christophe Kosinski Switzerland 7 55 0.5× 192 1.8× 142 1.4× 27 0.4× 42 1.2× 21 315
Nicole Zhang United States 7 70 0.6× 33 0.3× 107 1.0× 32 0.5× 32 0.9× 36 306
Adelina Tsakova Bulgaria 12 68 0.6× 103 1.0× 89 0.9× 87 1.4× 24 0.7× 39 383
Xikang Fan China 10 70 0.6× 56 0.5× 42 0.4× 52 0.8× 21 0.6× 33 333
Annie Lacroux France 12 102 0.9× 89 0.8× 46 0.4× 64 1.0× 36 1.0× 15 525
Conghui Liu China 9 121 1.0× 51 0.5× 46 0.4× 30 0.5× 29 0.8× 23 464
Jorge Nahas-Neto Brazil 11 62 0.5× 176 1.7× 82 0.8× 39 0.6× 19 0.5× 19 443

Countries citing papers authored by Imad Brema

Since Specialization
Citations

This map shows the geographic impact of Imad Brema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imad Brema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imad Brema more than expected).

Fields of papers citing papers by Imad Brema

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imad Brema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imad Brema. The network helps show where Imad Brema may publish in the future.

Co-authorship network of co-authors of Imad Brema

This figure shows the co-authorship network connecting the top 25 collaborators of Imad Brema. A scholar is included among the top collaborators of Imad Brema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imad Brema. Imad Brema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brema, Imad, et al.. (2025). Knowledge, Attitudes, and Concerns of Sudanese Doctors Regarding the Use of Artificial Intelligence Tools in Sudan. Sudan Journal of Medical Sciences. 20(2). 197–204.
4.
Brema, Imad, et al.. (2022). Single nucleotide polymorphism rs 2070874 at Interleukin-4 is associated with increased risk of type 1 diabetes mellitus independently of human leukocyte antigens. International Journal of Immunopathology and Pharmacology. 36. 1190310426–1190310426. 5 indexed citations
5.
Brema, Imad, et al.. (2022). Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Treatment in Type 1 Diabetes in a Tertiary Care Center in Saudi Arabia. SHILAP Revista de lepidopterología. 12(1). 10–15. 4 indexed citations
6.
Almalki, Mussa, et al.. (2021). Plurihormonal pituitary macroadenoma:  a case report. Journal of Medical Case Reports. 15(1). 407–407. 4 indexed citations
7.
Almalki, Mussa, et al.. (2021). Management of Diabetes Insipidus following Surgery for Pituitary and Suprasellar Tumors. Sultan Qaboos University medical journal. 21(3). 354–364. 16 indexed citations
8.
Ekhzaimy, Aishah, et al.. (2021). The Relationship Between Thyroid Function and Body Composition, Leptin, Adiponectin, and Insulin Sensitivity in Morbidly Obese Euthyroid Subjects Compared to Non-obese Subjects. Clinical Medicine Insights Endocrinology and Diabetes. 14. 3077651563–3077651563. 9 indexed citations
9.
Brema, Imad, et al.. (2021). Association of single‐nucleotide polymorphisms in tumour necrosis factor and human leukocyte antigens genes with type 1 diabetes. International Journal of Immunogenetics. 48(4). 326–335. 4 indexed citations
10.
Almalki, Mussa, et al.. (2020). Contemporary Management of Clinically Non-functioning Pituitary Adenomas: A Clinical Review. Clinical Medicine Insights Endocrinology and Diabetes. 13. 2455243244–2455243244. 23 indexed citations
11.
Brema, Imad, et al.. (2019). The association of health literacy with glycemic control in Saudi patients with type 2 diabetes. Saudi Medical Journal. 40(7). 675–680. 13 indexed citations
12.
Brema, Imad, et al.. (2018). Plasma Visfatin is reduced in Subjects with the Metabolic Syndrome and Pre-Diabetes. 2(3). 1 indexed citations
13.
Alshahrani, Fahad, et al.. (2018). Management of acromegaly: an exploratory survey of physicians from the Middle East and North Africa. HORMONES. 17(3). 373–381. 6 indexed citations
14.
Mueller, O. Thomas, et al.. (2018). Resistance to thyroid hormone-beta co-existing with partially empty sella in a Jordanian male. Endocrinology Diabetes and Metabolism Case Reports. 2018. 4 indexed citations
15.
Almalki, Mussa, et al.. (2018). The Effect of Vitamin D Replacement on Subjects with Subclinical Hypothyroidism and Vitamin D Deficiency. 2(1). 1–4. 3 indexed citations
16.
Alswailem, Meshael, Ebtesam Qasem, Avaniyapuram Kannan Murugan, et al.. (2017). Mutational analysis of rare subtypes of congenital adrenal hyperplasia in a highly inbred population. Molecular and Cellular Endocrinology. 461. 105–111. 10 indexed citations
17.
Thabit, Hood, Nicole Burns, Imad Brema, et al.. (2013). Prevalence and predictors of diabetes and cardiometabolic risk among construction workers in Ireland: The Construction Workers Health Trust screening study. Diabetes and Vascular Disease Research. 10(4). 337–345. 28 indexed citations
19.
Hernández‐Álvarez, María Isabel, Hood Thabit, Nicole Burns, et al.. (2009). Subjects With Early-Onset Type 2 Diabetes Show Defective Activation of the Skeletal Muscle PGC-1α/Mitofusin-2 Regulatory Pathway in Response to Physical Activity. Diabetes Care. 33(3). 645–651. 157 indexed citations
20.
Thabit, Hood, Gillian Martin, Imad Brema, et al.. (2008). Immigrant patients with type 2 diabetes mellitus have poorer initial and on-going glycemic control than a matched population of Irish patients.. PubMed. 101(6). 177–80. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026